A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases 论文

2023Nature Aging引用 233
DOIPDF
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchMachine Learning in Healthcare
Machine Learning in HealthcareAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
相关技术:Machine Learning in Healthcare
关系图谱

A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases · 相关事件

暂无数据